Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry

Bente Glintborg; Mikkel Ostergaard; Niels Steen Krogh; Martin Dehn Andersen; Ulrik Tarp; Anne Gitte Loft; Hanne Lindegaard; Mette Holland-Fischer; Henrik Nordin; Dorte Vendelbo Jensen; Christian Holkmann Olsen; Merete Lund Hetland

doi:10.1002/art.37876

Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry

Bente Glintborg, Mikkel Ostergaard, Niels Steen Krogh, Martin Dehn Andersen, Ulrik Tarp, Anne Gitte Loft, Hanne Lindegaard, Mette Holland-Fischer, Henrik Nordin, Dorte Vendelbo Jensen, Christian Holkmann Olsen, Merete Lund Hetland

Department for Rheumatology and Spine Diseases

192 Citations (Scopus)

Abstract

To describe the frequency of treatment switching and outcomes among patients with psoriatic arthritis (PsA) who switched tumor necrosis factor α inhibitor (TNFi) agents in routine care.

Original language	English
Journal	Excerpta Medica. Section 31: Arthritis and Rheumatism
Volume	65
Issue number	5
Pages (from-to)	1213-23
Number of pages	11
ISSN	0014-4355
DOIs	https://doi.org/10.1002/art.37876
Publication status	Published - May 2013

Access to Document

10.1002/art.37876

Fingerprint

Dive into the research topics of 'Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry'. Together they form a unique fingerprint.

Cite this

Glintborg, B., Ostergaard, M., Krogh, N. S., Andersen, M. D., Tarp, U., Loft, A. G., Lindegaard, H., Holland-Fischer, M., Nordin, H., Jensen, D. V., Olsen, C. H., & Hetland, M. L. (2013). Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry. Excerpta Medica. Section 31: Arthritis and Rheumatism, 65(5), 1213-23. https://doi.org/10.1002/art.37876

Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry. / Glintborg, Bente ; Ostergaard, Mikkel; Krogh, Niels Steen et al.
In: Excerpta Medica. Section 31: Arthritis and Rheumatism, Vol. 65, No. 5, 05.2013, p. 1213-23.

Research output: Contribution to journal › Journal article › Research › peer-review

Glintborg, B , Ostergaard, M, Krogh, NS, Andersen, MD, Tarp, U, Loft, AG, Lindegaard, H, Holland-Fischer, M, Nordin, H, Jensen, DV, Olsen, CH & Hetland, ML 2013, 'Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry', Excerpta Medica. Section 31: Arthritis and Rheumatism, vol. 65, no. 5, pp. 1213-23. https://doi.org/10.1002/art.37876

Glintborg B , Ostergaard M, Krogh NS, Andersen MD, Tarp U, Loft AG et al. Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry. Excerpta Medica. Section 31: Arthritis and Rheumatism. 2013 May;65(5):1213-23. doi: 10.1002/art.37876

Glintborg, Bente ; Ostergaard, Mikkel ; Krogh, Niels Steen et al. / Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy : Results from the Danish Nationwide DANBIO Registry. In: Excerpta Medica. Section 31: Arthritis and Rheumatism. 2013 ; Vol. 65, No. 5. pp. 1213-23.

@article{b7c702b277a641ecab408019c145a8a4,

title = "Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry",

abstract = "To describe the frequency of treatment switching and outcomes among patients with psoriatic arthritis (PsA) who switched tumor necrosis factor α inhibitor (TNFi) agents in routine care.",

author = "Bente Glintborg and Mikkel Ostergaard and Krogh, \{Niels Steen\} and Andersen, \{Martin Dehn\} and Ulrik Tarp and Loft, \{Anne Gitte\} and Hanne Lindegaard and Mette Holland-Fischer and Henrik Nordin and Jensen, \{Dorte Vendelbo\} and Olsen, \{Christian Holkmann\} and Hetland, \{Merete Lund\}",

note = "Copyright {\textcopyright} 2013 by the American College of Rheumatology.",

year = "2013",

month = may,

doi = "10.1002/art.37876",

language = "English",

volume = "65",

pages = "1213--23",

journal = "Excerpta Medica. Section 31: Arthritis and Rheumatism",

issn = "0014-4355",

publisher = "Excerpta Medica",

number = "5",

}

TY - JOUR

T1 - Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy

T2 - Results from the Danish Nationwide DANBIO Registry

AU - Glintborg, Bente

AU - Ostergaard, Mikkel

AU - Krogh, Niels Steen

AU - Andersen, Martin Dehn

AU - Tarp, Ulrik

AU - Loft, Anne Gitte

AU - Lindegaard, Hanne

AU - Holland-Fischer, Mette

AU - Nordin, Henrik

AU - Jensen, Dorte Vendelbo

AU - Olsen, Christian Holkmann

AU - Hetland, Merete Lund

PY - 2013/5

Y1 - 2013/5

N2 - To describe the frequency of treatment switching and outcomes among patients with psoriatic arthritis (PsA) who switched tumor necrosis factor α inhibitor (TNFi) agents in routine care.

AB - To describe the frequency of treatment switching and outcomes among patients with psoriatic arthritis (PsA) who switched tumor necrosis factor α inhibitor (TNFi) agents in routine care.

UR - https://www.scopus.com/pages/publications/84876572244

U2 - 10.1002/art.37876

DO - 10.1002/art.37876

M3 - Journal article

C2 - 23460467

SN - 0014-4355

VL - 65

SP - 1213

EP - 1223

JO - Excerpta Medica. Section 31: Arthritis and Rheumatism

JF - Excerpta Medica. Section 31: Arthritis and Rheumatism

IS - 5

ER -

Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry

Abstract

Access to Document

Other files and links

Fingerprint

Cite this